ScholarWorks@SUNGKYUNKWAN UNIVERSITY

Detailed Information

Cited 14 time in webofscience Cited 0 time in scopus
Metadata Downloads

Neoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.

Full metadata record
DC Field Value Language
dc.contributor.authorFasching, PA[Fasching, Peter A.]-
dc.contributor.authorBardia, A[Bardia, Aditya]-
dc.contributor.authorQuiroga, V[Quiroga, Vanesa]-
dc.contributor.authorPark, YH[Park, Yeon Hee]-
dc.contributor.authorBlancas, I[Blancas, Isabel]-
dc.contributor.authorAlonso, JL[Alonso, Jose Luis]-
dc.contributor.authorVasilyev, A[Vasilyev, Alexander]-
dc.contributor.authorAdamchuk, H[Adamchuk, Hryhoriy]-
dc.contributor.authorSalgado, MRT[Salgado, Marcelo Ramos Tejo]-
dc.contributor.authorYardley, DA[Yardley, Denise A.]-
dc.contributor.authorSpera, G[Spera, Gonzalo]-
dc.contributor.authorXue, C[Xue, Cloris]-
dc.contributor.authorFerreira, E[Ferreira, Erika]-
dc.contributor.authorCrnjevic, TB[Crnjevic, Tanja Badovinac]-
dc.contributor.authorPerez-Moreno, PD[Perez-Moreno, Pablo Diego]-
dc.contributor.authorLopez-Valverde, V[Lopez-Valverde, Vanesa]-
dc.contributor.authorSteinseifer, J[Steinseifer, Jutta]-
dc.contributor.authorFernando, TM[Fernando, Tharu M.]-
dc.contributor.authorMoore, HM[Moore, Heather M.]-
dc.contributor.authorHurvitz, SA[Hurvitz, Sara A.]-
dc.date.accessioned2023-01-09T01:48:30Z-
dc.date.available2023-01-09T01:48:30Z-
dc.date.created2023-01-09-
dc.date.issued2022-06-01-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://scholarworks.bwise.kr/skku/handle/2021.sw.skku/101791-
dc.language영어-
dc.language.isoen-
dc.publisherLIPPINCOTT WILLIAMS & WILKINS-
dc.titleNeoadjuvant giredestrant (GDC-9545) plus palbociclib (P) versus anastrozole (A) plus P in postmenopausal women with estrogen receptor-positive, HER2-negative, untreated early breast cancer (ER+/HER2-eBC): Final analysis of the randomized, open-label, international phase 2 coopERA BC study.-
dc.typeArticle-
dc.contributor.affiliatedAuthorPark, YH[Park, Yeon Hee]-
dc.identifier.wosid000863680301687-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL ONCOLOGY, v.40, no.16-
dc.relation.isPartOfJOURNAL OF CLINICAL ONCOLOGY-
dc.citation.titleJOURNAL OF CLINICAL ONCOLOGY-
dc.citation.volume40-
dc.citation.number16-
dc.type.rimsART-
dc.type.docTypeMeeting Abstract-
dc.description.journalClass1-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalResearchAreaOncology-
dc.relation.journalWebOfScienceCategoryOncology-
Files in This Item
There are no files associated with this item.
Appears in
Collections
Medicine > Department of Medicine > 1. Journal Articles
Show simple item record

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher PARK, YEON HEE photo

PARK, YEON HEE
Medicine (Medicine)
Read more

Altmetrics

Total Views & Downloads

STATISTICS
Total View :5,567,239
Today View :3,068

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어